Berenberg lowered the firm’s price target on Bayer (BAYRY) to EUR 22 from EUR 28 and keeps a Hold rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAYRY:
- Cytokinetics partnership demonstrates value of aficamten, says JMP Securities
- Cytokinetics, Bayer enter collaboration and license pact for aficamten in Japan
- Bayer price target lowered to EUR 30 from EUR 35 at Morgan Stanley
- Bayer price target lowered to EUR 25 from EUR 34 at JPMorgan
- Bayer price target lowered to EUR 23 from EUR 29 at Deutsche Bank